The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China

被引:4
作者
Ge, Jingjing [1 ]
Lei, Yaxin [1 ]
Wen, Qing [1 ]
Zhang, Yue [1 ]
Kong, Xiaoshuang [1 ]
Wang, Wenhua [1 ]
Qian, Siyu [1 ]
Hou, Huting [1 ]
Wang, ZeYuan [1 ]
Wu, Shaoxuan [1 ]
Dong, Meng [1 ]
Ding, Mengjie [1 ]
Wu, Xiaolong [1 ]
Feng, Xiaoyan [1 ]
Zhu, Linan [1 ]
Zhang, Mingzhi [1 ]
Chen, Qingjiang [1 ]
Zhang, Xudong [1 ]
机构
[1] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
基金
中国国家自然科学基金;
关键词
follicular lymphoma; prognostic nutritional index; lymphocyte; albumin; prognosis; HIGH-RISK; VALIDATION;
D O I
10.3389/fnut.2022.981338
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
ObjectiveThe prognostic nutritional index (PNI) is an important prognostic factor for survival outcomes in various hematological malignancies. The current study focused on exploring the predictive value of the PNI in newly diagnosed follicular lymphoma (FL) in China. Materials and methodsThe clinical indicators and follow-up data of 176 patients who received chemotherapy or immunotherapy combined with chemotherapy with FL in our hospital from January 2016 to March 2022 were retrospectively analyzed. Cox proportional hazard model was used for univariate and multivariate analyses. Kaplan-Meier curves were used to calculate survival rates and draw survival curves. The log-rank test was applied to compare differences between groups. ResultsThe optimal cut-off value of PNI was 44.3. All patients were divided into a high PNI group (>44.3) and a low PNI group (<= 44.3). The low PNI group had a low CR rate and a high risk of death, with a tendency toward POD24, and Both OS and PFS were worse than those in the high PNI group. PNI was able to predict OS and PFS in FL patients and was the only independent predictor of OS (P = 0.014 HR 5.024; 95%CI 1.388 similar to 18.178) in multivariate analysis. PNI could re-stratify patients into groups of high FLIPI score, high FLIPI2 score, no POD24, and rituximab combined with chemotherapy. Moreover, integrating PNI into the FLIPI and FLIPI2 models improved the area under the curve (AUC) for more accurate survival prediction and prognosis. ConclusionPNI is a significant prognostic indicator for newly diagnosed FL in China that can early identify patients with poor prognosis and guide clinical treatment decisions.
引用
收藏
页数:12
相关论文
共 42 条
  • [1] Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study
    Bachy, Emmanuel
    Seymour, John F.
    Feugier, Pierre
    Offner, Fritz
    Lopez-Guillermo, Armando
    Belada, David
    Xerri, Luc
    Catalano, John V.
    Brice, Pauline
    Lemonnier, Francois
    Martin, Alejandro
    Casasnovas, Olivier
    Pedersen, Lars M.
    Dorvaux, Veronique
    Simpson, David
    Leppa, Sirpa
    Gabarre, Jean
    da Silva, Maria G.
    Glaisner, Sylvie
    Ysebaert, Loic
    Vekhoff, Anne
    Intragumtornchai, Tanin
    Le Gouill, Steven
    Lister, Andrew
    Estell, Jane A.
    Milone, Gustavo
    Sonet, Anne
    Farhi, Jonathan
    Zeuner, Harald
    Tilly, Herve
    Salles, Gilles
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) : 2815 - +
  • [2] Prognostic Nutritional Index predicts morbidity after curative surgery for colorectal cancer
    Bailon-Cuadrado, Martin
    Perez-Saborido, Baltasar
    Sanchez-Gonzalez, Javier
    Rodriguez-Lopez, Mario
    Velasco-Lopez, Rosalia
    Sarmentero-Prieto, Jose C.
    Blanco-Alvarez, Jose, I
    Pacheco-Sanchez, David
    [J]. CIRUGIA ESPANOLA, 2019, 97 (02): : 71 - 80
  • [3] Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials
    Casulo, Carla
    Dixon, Jesse G.
    Le-Rademacher, Jennifer
    Hoster, Eva
    Hochster, Howard S.
    Hiddemann, Wolfgang
    Marcus, Robert
    Kimby, Eva
    Herold, Michael
    Sebban, Catherine
    Gyan, Emmanuel
    Foon, Kenneth
    Nielsen, Tina
    Vitolo, Umberto
    Salles, Gilles A.
    Shi, Qian
    Flowers, Christopher R.
    [J]. BLOOD, 2022, 139 (11) : 1684 - 1693
  • [4] Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
    Casulo, Carla
    Byrtek, Michelle
    Dawson, Keith L.
    Zhou, Xiaolei
    Farber, Charles M.
    Flowers, Christopher R.
    Hainsworth, John D.
    Maurer, Matthew J.
    Cerhan, James R.
    Link, Brian K.
    Zelenetz, Andrew D.
    Friedberg, Jonathan W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (23) : 2516 - U55
  • [5] Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
    Cheson, Bruce D.
    Fisher, Richard I.
    Barrington, Sally F.
    Cavalli, Franco
    Schwartz, Lawrence H.
    Zucca, Emanuele
    Lister, T. Andrew
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 3059 - +
  • [6] Diagnosis and management of follicular lymphoma: A comprehensive review
    Dada, Reyad
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2019, 103 (03) : 152 - 163
  • [7] Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines tor diagnosis, treatment and follow-up
    Dreyling, M.
    Ghielmini, M.
    Rule, S.
    Salles, G.
    Ladetto, M.
    Tonino, S. H.
    Herfarth, K.
    Seymour, J. F.
    Jerkeman, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 (03) : 298 - 308
  • [8] Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
    Federico, Massimo
    Bellei, Monica
    Marcheselli, Luigi
    Luminari, Stefano
    Lopez-Guillermo, Armando
    Vitolo, Umberto
    Pro, Barbara
    Pileri, Stefano
    Pulsoni, Alessandro
    Soubeyran, Pierre
    Cortelazzo, Sergio
    Martinelli, Giovanni
    Martelli, Maurizio
    Rigacci, Luigi
    Arcaini, Luca
    Di Raimondo, Francesco
    Merli, Francesco
    Sabattini, Elena
    McLaughlin, Peter
    Solal-Celigny, Philippe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) : 4555 - 4562
  • [9] Follicular lymphoma: 2020 update on diagnosis and management
    Freedman, Arnold
    Jacobsen, Eric
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (03) : 316 - 327
  • [10] Prognostic impact of nutritional and inflammation-based risk scores in follicular lymphoma in the era of anti-CD20 targeted treatment strategies
    Gebauer, Niklas
    Mengler, Britta
    Kopelke, Svenja
    Frydrychowicz, Alex
    Furschke, Alexander
    Hackenbroch, Carsten
    Bauer, Arthur
    Riecke, Armin
    von Bubnoff, Nikolaus
    Fetscher, Sebastian
    Witte, Hanno M.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1789 - 1801